Myriad Genetics Cut to Underweight as Piper Questions Path to Profit
Piper Sandler double-downgraded MYGN, saying the current model cannot grow or cut its way to profit.
Already have an account? Sign in.
Piper Sandler double-downgraded MYGN, saying the current model cannot grow or cut its way to profit.
Vicor lifts Q3 sales growth guidance from nearly 10% to more than 20% after royalties from a new non-exclusive Vertical Power Delivery license.
Paramount must spend $1.5B more on U.S. films, release 156 movies in five years and create an independent CNN-CBS board to close its $110B Warner deal.
CF, Nutrien slip as investors weigh extra supply risk.